Omlonti Solution/ Drops
Product Images NDC 84826-002

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Omlonti (NDC 84826-002). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ocuvex Therapeutics, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (2.5 mL Bottle Label)

Label for Omlonti (omidenepag isopropyl ophthalmic solution) 0.002% sterile drops, 2.5 mL container, distributed by Ocuvex Therapeutics, Inc. The label includes an NDC number 84826-002-01 and a barcode.*

FDA Label Image

Principal Display Panel (2.5 mL Carton Label)

Packaging label for Omlonti 0.02 mg/mL ophthalmic solution drops by Ocuvex Therapeutics, Inc. The label indicates a 2.5 mL bottle for topical ocular use. It features the product name, active ingredient omidenepag isopropyl concentration, barcode, storage instructions, dosage recommendations, and manufacturer/distributor information.*

FDA Label Image

Image (Omlonti Ophthalmic Solution Fig 1)

Illustration showing parts of the Omlonti multi-dose ophthalmic solution bottle. The diagram labels the tamper-evident overcap, inner screw cap, tip of the bottle, and the multi-dose bottle itself. The image highlights the bottle components designed for dispensing the solution drops.*

FDA Label Image

Step 9 (Omlonti Ophthalmic Solution Fig 10)

An illustration depicting an eye with arrows below it indicating a side-to-side motion, likely demonstrating how to apply or distribute ophthalmic solution or drops around the eye area.*

FDA Label Image

Step 10 (Omlonti Ophthalmic Solution Fig 11)

An instructional illustration showing a finger gently pulling down the lower eyelid of a closed eye, likely demonstrating how to apply ophthalmic drops.*

FDA Label Image

Step 1 (Omlonti Ophthalmic Solution Fig 2)

An instructional illustration depicting handwashing under a faucet. The image shows a pair of hands with water flowing over them, demonstrating proper hand hygiene.*

FDA Label Image

Step 2 (Omlonti Ophthalmic Solution Fig 3)

A black and white line drawing illustrating how to use an ophthalmic solution dropper bottle. The image shows one hand holding the bottle upside down while the other hand twists the cap to open it, preparing the bottle for use.*

FDA Label Image

Step 3 (Omlonti Ophthalmic Solution Fig 4)

An instructional illustration showing a person removing the protective cap from the tip of an ophthalmic solution dropper bottle, demonstrating how to prepare the bottle for administration.*

FDA Label Image

Step 4 (Omlonti Ophthalmic Solution Fig 5)

An instructional illustration showing a hand holding a small ophthalmic dropper bottle. Curved arrows indicate the motion of gently shaking or rocking the bottle up and down.*

FDA Label Image

Step 5 (Omlonti Ophthalmic Solution Fig 6)

An instructional illustration showing hands holding an ophthalmic drop bottle, with one hand twisting or removing the cap. This image likely demonstrates how to open the eye drop bottle before use.*

FDA Label Image

Step 6 (Omlonti Ophthalmic Solution Fig 7)

An instructional illustration depicting a single open eye with a finger positioned below the lower eyelid, demonstrating how to apply ophthalmic solution or drops into the eye.*

FDA Label Image

Step 7 (Omlonti Ophthalmic Solution Fig 8)

Illustration of a person applying ophthalmic solution drops to the eye, demonstrating the proper technique by pulling down the lower eyelid and directing the drop into the eye.*

FDA Label Image

Step 8 (Omlonti Ophthalmic Solution Fig 9)

An instructional illustration showing a person administering ophthalmic drops to their eye. The individual tilts their head back, holds the lower eyelid down with one finger to form a pocket, and uses the other hand to position the dropper bottle above the eye to dispense the drops.*

FDA Label Image

Chemical Structure (Omlonti Ophthalmic Solution Structure)

Chemical structure of omidenepag isopropyl, the active ingredient in Omlonti ophthalmic solution. The diagram shows the molecular framework including rings, nitrogen, oxygen, sulfur atoms, and bonds representing the compound's chemical composition.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.